Company Filing History:
3 out of 2,079 
1 out of 32 
1 out of 1 Years Active: 1990-1993
Title: The Innovative Contributions of Michel A De Cleyn
Introduction
Michel A De Cleyn, an accomplished inventor from Merksplas, Belgium, has made significant strides in the field of pharmaceuticals. With a total of five patents to his name, De Cleyn's work reflects a deep commitment to innovation and the advancement of medicinal chemistry. His unique contributions showcase the synergy between scientific research and practical application in the pharmaceutical industry.
Latest Patents
Among De Cleyn's latest patents are several derivatives that demonstrate his expertise in developing complex chemical compounds. Notably, he holds a patent for N-(4-piperidinyl) (dihydroxybenzofuran) and Piperidine derivatives, the latter involving formulas where A is a radical of particular chemical structure with the potential for hydrogen atom substitutions. These advancements in piperidine derivatives underline a promising avenue for new therapeutic agents.
Career Highlights
Throughout his career, Michel A De Cleyn has honed his skills at Janssen Pharmaceutica, a company renowned for its innovative healthcare solutions. His work there has been pivotal in bridging the gap between scientific research and drug development, leading to robust advancements in treatment options for various conditions. The expertise he has amassed over the years has made him a valuable asset in the pharmaceutical field.
Collaborations
De Cleyn has collaborated with notable peers, including Georges H Van Daele and Freddy F Vlaeminck. These collaborations have facilitated a productive exchange of ideas, further enriching the inventive processes that shape their shared work in the pharmaceutical industry.
Conclusion
Michel A De Cleyn stands out as an influential figure in the realm of pharmaceuticals, with a remarkable portfolio of patents that exemplify his innovative spirit. His ongoing contributions and collaborations underscore the importance of teamwork and creativity in advancing healthcare solutions. As he continues to work within this dynamic field, the impact of his inventions will undoubtedly resonate within the pharmaceutical community for years to come.